NeuroSense Therapeutics(NRSN) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist

1.070
+0.003+0.24%

Close Mar 21 16:00 ET

1.060
-0.010-0.93%

Post 19:44 ET

24.85MMarket Cap-1.41P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
Business WireMar 20 10:30 ET
$NRSN Earnings Preview: Recent $NRSN Insider Trading, Hedge Fund Activity, and More
Quiver QuantitativeMar 17 17:06 ET
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
Business WireMar 17 08:30 ET
NeuroSense Therapeutics Reports Positive Phase 2b Study Results for ALS Treatment
TipRanksFeb 19 09:27 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Elevance Health (ELV) and Genmab (GMAB)
TipRanksFeb 4 08:40 ET · Ratings
A. G. P. Maintains NeuroSense Therapeutics(NRSN.US) With Buy Rating, Maintains Target Price $7.5
Moomoo NewsFeb 4 08:31 ET · Ratings

Comments

Jaguar8

Mar 21 09:02

🟡Watchlist, MARCH 21,2025, Friday. NFA -DrJag8. Sorry I can’t answer questions. It was a long long day for me.

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...

Jaguar8

Mar 17 20:37

NEWS

$NeuroSense Therapeutics (NRSN.US)$
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
Monday, 17th March at 8:30 am
NeuroSense's Breakthrough ALS Combination Therapy PrimeC Has Demonstrated Unprecedentedly Strong Clinical Efficacy; Wall Street Maintains Buy Rating with AGP giving the company a $7.50 Price Target Representing a Significant Premium Over Current Prices; Recently Announced Bindin...

Jaguar8

Jan 7 08:34

🟢 Watchlist JANUARY 7,2025, Tuesday- NFA. A lot of tech news coming tom which may overshadow news today. Expect delayed market reaction until next week.

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, ...

Jaguar8

Jan 6 22:01

NEWS

$NeuroSense Therapeutics (NRSN.US)$
NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement
Monday, 6th January at 9:00 am
• NeuroSense in Compliance with all Nasdaq Listing Requirements
CAMBRIDGE, Mass., Jan. 6, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the Company received formal written notice from The Nas...

Jaguar8

Dec 23, 2024 22:05

NEWS

$NeuroSense Therapeutics (NRSN.US)$
NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS
Monday, 23rd December at 9:00 am
• Binding Term Sheet with a leading global pharmaceutical company includes a substantial upfront payment and funding for the Phase 3 study
• Additionally, milestone payments and double-digit royalties on annual net sales
• The transaction is subject to finalization of a definitive agreement, anticipated in Q1 2025
CAMBRIDGE, Mass., Dec. 23, 2024 /...

Market Insights

Symbol Mini Chart % Chg